Pacira BioSciences, Inc. PCRX Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s interest expense?
- Pacira BioSciences, Inc. (PCRX) reported interest expense of $3.7M in Q1 2026.
- How has Pacira BioSciences, Inc.'s interest expense changed year-over-year?
- Pacira BioSciences, Inc.'s interest expense decreased by 19.2% year-over-year, from $4.58M to $3.7M.
- What is the long-term trend for Pacira BioSciences, Inc.'s interest expense?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s interest expense has grown at a -13.9% compound annual growth rate (CAGR), from $31.75M to $17.45M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.